The FDA has taken formal steps to restrict or eliminate large-scale outsourcing compounding of these drug classes, and the regulatory picture remains in active development at the time this article was written
Individuals with a BMI of 30 kg/m or higher may qualify directly, while those with a BMI of 27 kg/m or higher may be eligible if they have weight-related health conditions like hypertension, type 2 diabetes , elevated cholesterol, or obstructive sleep apnea
Why "GLP-1 patch" became a viral search term The GLP-1 patch category exists because of search demand, not scientific discovery
This allows for a comprehensive understanding of potential interactions and side effects
Not into the regular trash
The FDA does not review the safety and efficacy of compounded products, which are custom-made alternatives to brand drugs designed to meet a specific patient's needs